Roy Rindler, MD
Dermatology · Oklahoma City, OKNPI 1235335712
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 495 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations.
Across 495 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novartis$1K
- Regeneron Healthcare Solutions, Inc.$961
- Lilly USA, LLC$722
- Johnson & Johnson$696
- Pfizer$545
- plus $4K from 32 others
What the payments were for
- Food & beverage$8,909100%
- Education$390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,163 |
| Novartis | 73 | $1,111 |
| Regeneron Healthcare Solutions, Inc. | 37 | $961 |
| Lilly USA, LLC | 42 | $722 |
| Johnson & Johnson | 48 | $696 |
| Pfizer | 30 | $545 |
| LEO Pharma Inc. | 28 | $508 |
| Sanofi | 22 | $462 |
| Amgen | 16 | $370 |
| Organogenesis Inc. | 15 | $364 |
| Sun Pharmaceutical Industries Inc. | 17 | $302 |
| E.r. Squibb & Sons, L.L.C. | 15 | $270 |
| Incyte Corporation | 11 | $216 |
| Mayne Pharma Commercial LLC | 8 | $135 |
| Dermavant Sciences, Inc. | 9 | $133 |
| Arcutis Biotherapeutics, Inc. | 8 | $117 |
| UCB, Inc. | 5 | $113 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $109 |
| Galderma Laboratories, L.p. | 5 | $85 |
| Boehringer Ingelheim | 4 | $73 |
| Genentech USA, Inc. | 4 | $56 |
| Almirall LLC | 2 | $56 |
| Kyowa Kirin, Inc. | 3 | $53 |
| Dermira, Inc. | 3 | $50 |
| VYNE Pharmaceuticals Inc. | 3 | $45 |
| Blueprint Medicines Corporation | 1 | $24 |
| Merck | 2 | $22 |
| Chiesi USA, Inc. | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Organon | 2 | $18 |
| Bristol Myers Squibb | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
| Biofrontera Inc. | 1 | $16 |
| Aclaris Therapeutics, Inc. | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $13 |
How this compares
$8,949 in reported general payments places this provider in the 75th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 219 | $990 |
| Clobetasol Propionate | 11 | $583 |
| Doxycycline Hyclate | 66 | $482 |
| Ketoconazole | 16 | $307 |
| Minoxidil | 12 | $195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $157 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
- Courtney CookOklahoma City$10K
- Clifford HendersonOklahoma City$9K
- Emily ArchbaldOklahoma City$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.